Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 10/2010

01-12-2010

I’m so tired: biological and genetic mechanisms of cancer-related fatigue

Auteurs: Andrea Barsevick, Marlene Frost, Aeilko Zwinderman, Per Hall, Michele Halyard, GENEQOL Consortium

Gepubliceerd in: Quality of Life Research | Uitgave 10/2010

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Objective

The goal of this paper is to discuss cancer-related fatigue (CRF) and address issues related to the investigation into potential biological and genetic causal mechanisms. The objectives are to: (1) describe CRF as a component of quality of life (QOL); (2) address measurement issues that have slowed progress toward an understanding of mechanisms underlying this symptom; (3) review biological pathways and genetic approaches that have promise for the exploration of causal mechanisms of CRF; and (4) offer directions for future research.

Methods

Review, synthesis, and interpretation of the literature.

Results

Until recently, CRF and QOL have been understood primarily as subjective patient-reported experiences. With increased understanding of human genetics, theories and research are being expanded to incorporate biological and genetic understandings of these subjective experiences. Proposed biological and genetic mechanisms of CRF that have been examined include cytokine dysregulation, hypothalamic–pituitary–adrenal (HPA) axis dysfunction, five hydroxy tryptophan (5-HT) neurotransmitter dysregulation, circadian rhythm disruption, alterations in adenosine triphosphate (ATP) and muscle metabolism, and vagal afferent activation. Approaches to the study of genetic mechanisms have also been addressed including candidate genes, genome-wide scanning, and gene expression. Based on the review and synthesis of the literature, directions for future research are proposed.

Conclusions

Understanding the biological and genetic basis of CRF has the potential to contribute to a more complete understanding of the genetic determinants of QOL.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Higginson, I. J., Armes, J., & Krishnasamy, M. (2004). Introduction, in fatigue in cancer. In J. Armes, M. Krishnasamy, & I. J. Higginson (Eds.), Fatigue in cancer (pp. xvii–xxi). Oxford: Oxford University Press. Higginson, I. J., Armes, J., & Krishnasamy, M. (2004). Introduction, in fatigue in cancer. In J. Armes, M. Krishnasamy, & I. J. Higginson (Eds.), Fatigue in cancer (pp. xvii–xxi). Oxford: Oxford University Press.
2.
go back to reference Cella, D., Davis, K., Breitbart, W., & Curt, G. (2001). Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. Journal of Clinical Oncology, 19(14), 3385–3391. PubMed Cella, D., Davis, K., Breitbart, W., & Curt, G. (2001). Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. Journal of Clinical Oncology, 19(14), 3385–3391. PubMed
3.
go back to reference Servaes, P., Verhagen, C., & Bleijenberg, G. (2002). Fatigue in cancer patients during and after treatment: Prevalence, correlates and interventions. European Journal of Cancer, 38(1), 27–43. CrossRefPubMed Servaes, P., Verhagen, C., & Bleijenberg, G. (2002). Fatigue in cancer patients during and after treatment: Prevalence, correlates and interventions. European Journal of Cancer, 38(1), 27–43. CrossRefPubMed
4.
go back to reference Smets, E. M., Garssen, B., Cull, A., & de Haes, J. C. (1996). Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. British Journal of Cancer, 73(2), 241–245. PubMed Smets, E. M., Garssen, B., Cull, A., & de Haes, J. C. (1996). Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. British Journal of Cancer, 73(2), 241–245. PubMed
5.
go back to reference Curt, G. A., Breitbart, W., Cella, D., Groopman, J. E., Horning, S. J., Itri, L. M., et al. (2000). Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. The Oncologist, 5(5), 353–360. CrossRefPubMed Curt, G. A., Breitbart, W., Cella, D., Groopman, J. E., Horning, S. J., Itri, L. M., et al. (2000). Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. The Oncologist, 5(5), 353–360. CrossRefPubMed
6.
go back to reference Lawrence, D. P., Kupelnick, B., Miller, K., Devine, D., & Lau, J. (2004). Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. Journal of the National Cancer Institute Monographs, 32, 40–50. CrossRefPubMed Lawrence, D. P., Kupelnick, B., Miller, K., Devine, D., & Lau, J. (2004). Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. Journal of the National Cancer Institute Monographs, 32, 40–50. CrossRefPubMed
7.
go back to reference Vogelzang, N. J., Breitbart, W., Cella, D., Curt, G. A., Groopman, J. E., Horning, S. J., et al. (1997). Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. The Fatigue Coalition. Seminars in Hematology, 34(3 Suppl 2), 4–12. PubMed Vogelzang, N. J., Breitbart, W., Cella, D., Curt, G. A., Groopman, J. E., Horning, S. J., et al. (1997). Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. The Fatigue Coalition. Seminars in Hematology, 34(3 Suppl 2), 4–12. PubMed
8.
go back to reference Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA, 273(1), 59–65. CrossRefPubMed Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA, 273(1), 59–65. CrossRefPubMed
9.
go back to reference Sprangers, M. A. G., Sloan, J. A., Barsevick, A., Chauhan, C., Dueck, A. C., Raat H., et al. (2010). Scientific Imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Quality of Life Research. doi: 10.​1007/​s11136-010-9759-5. Sprangers, M. A. G., Sloan, J. A., Barsevick, A., Chauhan, C., Dueck, A. C., Raat H., et al. (2010). Scientific Imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Quality of Life Research. doi: 10.​1007/​s11136-010-9759-5.
10.
go back to reference Andrykowski, M. A., Schmidt, J. E., Salsman, J. M., Beacham, A. O., & Jacobsen, P. B. (2005). Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. Journal of Clinical Oncology, 23(27), 6613–6622. CrossRefPubMed Andrykowski, M. A., Schmidt, J. E., Salsman, J. M., Beacham, A. O., & Jacobsen, P. B. (2005). Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. Journal of Clinical Oncology, 23(27), 6613–6622. CrossRefPubMed
11.
go back to reference Alexander, S., Minton, O., Andrews, P., & Stone, P. (2009). A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. European Journal of Cancer, 45(3), 384–392. CrossRefPubMed Alexander, S., Minton, O., Andrews, P., & Stone, P. (2009). A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. European Journal of Cancer, 45(3), 384–392. CrossRefPubMed
12.
go back to reference NCCN. (2010). The complete library of NCCN clinical practice guidelines in oncology. Fort Washington, PA: National Comprehensive Cancer Network. NCCN. (2010). The complete library of NCCN clinical practice guidelines in oncology. Fort Washington, PA: National Comprehensive Cancer Network.
13.
go back to reference Barsevick, A. M., Cleeland, C. S., Manning, D. C., O’Mara, A. M., Reeve, B. B., Scott, J. A., et al. (2010). ASCPRO Recommendations for the assessment of fatigue as an outcome in clinical trials. Journal of Pain and Symptom Management, 39(6), 1086–1099. CrossRefPubMed Barsevick, A. M., Cleeland, C. S., Manning, D. C., O’Mara, A. M., Reeve, B. B., Scott, J. A., et al. (2010). ASCPRO Recommendations for the assessment of fatigue as an outcome in clinical trials. Journal of Pain and Symptom Management, 39(6), 1086–1099. CrossRefPubMed
14.
go back to reference Mendoza, T. R., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. K., et al. (1999). The rapid assessment of fatigue severity in cancer patients: Use of the brief fatigue inventory. Cancer, 85(5), 1186–1196. CrossRefPubMed Mendoza, T. R., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. K., et al. (1999). The rapid assessment of fatigue severity in cancer patients: Use of the brief fatigue inventory. Cancer, 85(5), 1186–1196. CrossRefPubMed
15.
go back to reference Piper, B. F., Lindsey, A. M., & Dodd, M. J. (1989). The development of an instrument to measure the subjective dimension of fatigue. In E. M. T. S. G. Funk & M. T. Campagne (Eds.), Key aspects of comfort: Management of pain, fatigue, and nausea (pp. 199–208). New York: Springer. Piper, B. F., Lindsey, A. M., & Dodd, M. J. (1989). The development of an instrument to measure the subjective dimension of fatigue. In E. M. T. S. G. Funk & M. T. Campagne (Eds.), Key aspects of comfort: Management of pain, fatigue, and nausea (pp. 199–208). New York: Springer.
16.
go back to reference Schwartz, A. L. (1998). The schwartz cancer fatigue scale: Testing reliability and validity. Oncology Nursing Forum, 25(4), 711. PubMed Schwartz, A. L. (1998). The schwartz cancer fatigue scale: Testing reliability and validity. Oncology Nursing Forum, 25(4), 711. PubMed
17.
go back to reference Smets, E. M., Garssen, B., Bonke, B., & De Haes, J. C. (1995). The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research, 39(3), 315–325. CrossRefPubMed Smets, E. M., Garssen, B., Bonke, B., & De Haes, J. C. (1995). The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research, 39(3), 315–325. CrossRefPubMed
18.
go back to reference Stein, K. D., Martin, S. C., Hann, D. M., & Jacobsen, P. B. (1998). A multidimensional measure of fatigue for use with cancer patients. Cancer Practice, 6(3), 143–152. CrossRefPubMed Stein, K. D., Martin, S. C., Hann, D. M., & Jacobsen, P. B. (1998). A multidimensional measure of fatigue for use with cancer patients. Cancer Practice, 6(3), 143–152. CrossRefPubMed
19.
go back to reference Belza, B. L. (1995). Comparison of self-reported fatigue in rheumatoid arthritis and controls. Journal of Rheumatology, 22(4), 639–643. PubMed Belza, B. L. (1995). Comparison of self-reported fatigue in rheumatoid arthritis and controls. Journal of Rheumatology, 22(4), 639–643. PubMed
20.
go back to reference Okuyama, T., Akechi, T., Kugaya, A., Okamura, H., Shima, Y., Maruguchi, M., et al. (2000). Development and validation of the cancer fatigue scale: A brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. Journal of Pain and Symptom Management, 19(1), 5–14. CrossRefPubMed Okuyama, T., Akechi, T., Kugaya, A., Okamura, H., Shima, Y., Maruguchi, M., et al. (2000). Development and validation of the cancer fatigue scale: A brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. Journal of Pain and Symptom Management, 19(1), 5–14. CrossRefPubMed
21.
go back to reference Lee, K. A., Hicks, G., & Nino-Murcia, G. (1991). Validity and reliability of a scale to assess fatigue. Psychiatry Research, 36(3), 291–298. CrossRefPubMed Lee, K. A., Hicks, G., & Nino-Murcia, G. (1991). Validity and reliability of a scale to assess fatigue. Psychiatry Research, 36(3), 291–298. CrossRefPubMed
22.
go back to reference Ware, J. E., Jr., Snow, K. K., Kosinski, M., & Gandek, B. (1993). SF-36 health survey manual and interpretation guide. Boston: The Health Institute, New England Medical Center. Ware, J. E., Jr., Snow, K. K., Kosinski, M., & Gandek, B. (1993). SF-36 health survey manual and interpretation guide. Boston: The Health Institute, New England Medical Center.
23.
go back to reference Alexander, S., Minton, O., Stone, P. C., Alexander, S., Minton, O., & Stone, P. C. (2009). Evaluation of screening instruments for cancer-related fatigue syndrome in breast cancer survivors. Journal of Clinical Oncology, 27(8), 1197–1201. CrossRefPubMed Alexander, S., Minton, O., Stone, P. C., Alexander, S., Minton, O., & Stone, P. C. (2009). Evaluation of screening instruments for cancer-related fatigue syndrome in breast cancer survivors. Journal of Clinical Oncology, 27(8), 1197–1201. CrossRefPubMed
24.
go back to reference Sadler, I. J., Jacobsen, P. B., Booth-Jones, M., Belanger, H., Weitzner, M. A., & Fields, K. K. (2002). Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. Journal of Pain and Symptom Management, 23(5), 406–416. CrossRefPubMed Sadler, I. J., Jacobsen, P. B., Booth-Jones, M., Belanger, H., Weitzner, M. A., & Fields, K. K. (2002). Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. Journal of Pain and Symptom Management, 23(5), 406–416. CrossRefPubMed
25.
26.
go back to reference Ryan, J. L., Carroll, J. K., Ryan, E. P., Mustian, K. M., Fiscella, K., & Morrow, G. R. (2007). Mechanisms of cancer-related fatigue. The Oncologist, 12(Suppl 1), 22–34. CrossRefPubMed Ryan, J. L., Carroll, J. K., Ryan, E. P., Mustian, K. M., Fiscella, K., & Morrow, G. R. (2007). Mechanisms of cancer-related fatigue. The Oncologist, 12(Suppl 1), 22–34. CrossRefPubMed
27.
go back to reference Morrow, G. R., Andrews, P. L., Hickok, J. T., Roscoe, J. A., Matteson, S., Morrow, G. R., et al. (2002). Fatigue associated with cancer and its treatment. Supportive Care in Cancer, 10(5), 389–398. CrossRefPubMed Morrow, G. R., Andrews, P. L., Hickok, J. T., Roscoe, J. A., Matteson, S., Morrow, G. R., et al. (2002). Fatigue associated with cancer and its treatment. Supportive Care in Cancer, 10(5), 389–398. CrossRefPubMed
28.
go back to reference Bower, J. E., Ganz, P. A., Aziz, N., Fahey, J. L., Cole, S. W., Bower, J. E., et al. (2003). T-cell homeostasis in breast cancer survivors with persistent fatigue. Journal of the National Cancer Institute, 95(15), 1165–1168. CrossRefPubMed Bower, J. E., Ganz, P. A., Aziz, N., Fahey, J. L., Cole, S. W., Bower, J. E., et al. (2003). T-cell homeostasis in breast cancer survivors with persistent fatigue. Journal of the National Cancer Institute, 95(15), 1165–1168. CrossRefPubMed
29.
go back to reference Greenberg, D. B., Gray, J. L., Mannix, C. M., Eisenthal, S., & Carey, M. (1993). Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. Journal of Pain and Symptom Management, 8(4), 196–200. CrossRefPubMed Greenberg, D. B., Gray, J. L., Mannix, C. M., Eisenthal, S., & Carey, M. (1993). Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. Journal of Pain and Symptom Management, 8(4), 196–200. CrossRefPubMed
30.
go back to reference Bower, J. E., Ganz, P. A., Aziz, N., & Fahey, J. L. (2002). Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosomatic Medicine, 64(4), 604–611. PubMed Bower, J. E., Ganz, P. A., Aziz, N., & Fahey, J. L. (2002). Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosomatic Medicine, 64(4), 604–611. PubMed
31.
go back to reference Levy, S., Herberman, R., Lippman, M., & d’Angelo, T. (1987). Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. Journal of Clinical Oncology, 5(3), 348–353. PubMed Levy, S., Herberman, R., Lippman, M., & d’Angelo, T. (1987). Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. Journal of Clinical Oncology, 5(3), 348–353. PubMed
32.
go back to reference Levy, S. M., Herberman, R. B., Maluish, A. M., Schlien, B., & Lippman, M. (1985). Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychology, 4(2), 99–113. CrossRefPubMed Levy, S. M., Herberman, R. B., Maluish, A. M., Schlien, B., & Lippman, M. (1985). Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychology, 4(2), 99–113. CrossRefPubMed
33.
go back to reference Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008). Cytokines and their relationship to the symptoms and outcome of cancer. Nature Reviews Cancer, 8(11), 887–899. CrossRefPubMed Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008). Cytokines and their relationship to the symptoms and outcome of cancer. Nature Reviews Cancer, 8(11), 887–899. CrossRefPubMed
34.
go back to reference Kurzrock, R. (2001). The role of cytokines in cancer-related fatigue. Cancer, 92(6 Suppl), 1684–1688. CrossRefPubMed Kurzrock, R. (2001). The role of cytokines in cancer-related fatigue. Cancer, 92(6 Suppl), 1684–1688. CrossRefPubMed
35.
go back to reference Menzies, H., Chochinov, H., & Breitbart, W. (2005). Cytokines, cancer, and depression: Connecting the dots [comment]. Journal of Supportive Oncology, 3, 55–57. PubMed Menzies, H., Chochinov, H., & Breitbart, W. (2005). Cytokines, cancer, and depression: Connecting the dots [comment]. Journal of Supportive Oncology, 3, 55–57. PubMed
36.
go back to reference Quesada, J. R., Talpaz, M., Rios, A., Kurzrock, R., & Gutterman, J. U. (1986). Clinical toxicity of interferons in cancer patients: a review. Journal of Clinical Oncology, 4(2), 234–243. PubMed Quesada, J. R., Talpaz, M., Rios, A., Kurzrock, R., & Gutterman, J. U. (1986). Clinical toxicity of interferons in cancer patients: a review. Journal of Clinical Oncology, 4(2), 234–243. PubMed
37.
go back to reference Maes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., et al. (1995). Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. Journal of Affective Disorders, 34(4), 301–309. CrossRefPubMed Maes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., et al. (1995). Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. Journal of Affective Disorders, 34(4), 301–309. CrossRefPubMed
38.
go back to reference Musselman, D. L., Miller, A. H., Porter, M. R., Manatunga, A., Gao, F., Penna, S., et al. (2001). Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. American Journal of Psychiatry, 158(8), 1252–1257. CrossRefPubMed Musselman, D. L., Miller, A. H., Porter, M. R., Manatunga, A., Gao, F., Penna, S., et al. (2001). Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. American Journal of Psychiatry, 158(8), 1252–1257. CrossRefPubMed
39.
go back to reference Schubert, C., Hong, S., Natarajan, L., Mills, P. J., Dimsdale, J. E., Schubert, C., et al. (2007). The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review. Brain, Behavior, and Immunity, 21(4), 413–427. CrossRefPubMed Schubert, C., Hong, S., Natarajan, L., Mills, P. J., Dimsdale, J. E., Schubert, C., et al. (2007). The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review. Brain, Behavior, and Immunity, 21(4), 413–427. CrossRefPubMed
40.
go back to reference Ahlberg, K., Ekman, T., & Gaston-Johansson, F. (2004). Levels of fatigue compared to levels of cytokines and hemoglobin during pelvic radiotherapy: A pilot study. Biological Research Nursing, 5(3), 203–210. CrossRef Ahlberg, K., Ekman, T., & Gaston-Johansson, F. (2004). Levels of fatigue compared to levels of cytokines and hemoglobin during pelvic radiotherapy: A pilot study. Biological Research Nursing, 5(3), 203–210. CrossRef
41.
go back to reference Meyers, C. A., Albitar, M., Estey, E., Meyers, C. A., Albitar, M., & Estey, E. (2005). Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer, 104(4), 788–793. CrossRefPubMed Meyers, C. A., Albitar, M., Estey, E., Meyers, C. A., Albitar, M., & Estey, E. (2005). Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer, 104(4), 788–793. CrossRefPubMed
42.
go back to reference Rich, T. A. (2007). Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis . The Journal of Supportive Oncology, 5(4), 167–174; discussion 176–177. Rich, T. A. (2007). Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis . The Journal of Supportive Oncology, 5(4), 167–174; discussion 176–177.
43.
go back to reference Bender, C. M., Sereika, S. M., Brufsky, A. M., Ryan, C. M., Vogel, V. G., Rastogi, P., et al. (2007). Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause, 14(6), 995–998. CrossRefPubMed Bender, C. M., Sereika, S. M., Brufsky, A. M., Ryan, C. M., Vogel, V. G., Rastogi, P., et al. (2007). Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause, 14(6), 995–998. CrossRefPubMed
44.
go back to reference Posener, J. A., Schildkraut, J. J., Samson, J. A., & Schatzberg, A. F. (1996). Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects. Psychoneuroendocrinology, 21(1), 33–38. CrossRefPubMed Posener, J. A., Schildkraut, J. J., Samson, J. A., & Schatzberg, A. F. (1996). Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects. Psychoneuroendocrinology, 21(1), 33–38. CrossRefPubMed
45.
go back to reference Bower, J. E., Ganz, P. A., Aziz, N., Bower, J. E., Ganz, P. A., & Aziz, N. (2005). Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosomatic Medicine, 67(2), 277–280. CrossRefPubMed Bower, J. E., Ganz, P. A., Aziz, N., Bower, J. E., Ganz, P. A., & Aziz, N. (2005). Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosomatic Medicine, 67(2), 277–280. CrossRefPubMed
46.
go back to reference Bailey, S. P., Davis, J. M., & Alhlborn, E. N. (1993). Neuroendocrine and substrate responses to altered brain 5-HT activity during prolonged exercise to fatigue. Journal of Applied Physiology, 74, 3006–3012. PubMed Bailey, S. P., Davis, J. M., & Alhlborn, E. N. (1993). Neuroendocrine and substrate responses to altered brain 5-HT activity during prolonged exercise to fatigue. Journal of Applied Physiology, 74, 3006–3012. PubMed
47.
go back to reference Andrews, P. L. R., Morrow, G. R., & Hickok, J. T. (2004). Mechanisms and models of fatigue associated with cancer and its treatment. Evidence of pre-clinical and clinical studies. In J. Armes, M. Krishnasamy, & I. Higginson (Eds.), Fatigue in cancer (pp. 51–87). Oxford: Oxford University Press. Andrews, P. L. R., Morrow, G. R., & Hickok, J. T. (2004). Mechanisms and models of fatigue associated with cancer and its treatment. Evidence of pre-clinical and clinical studies. In J. Armes, M. Krishnasamy, & I. Higginson (Eds.), Fatigue in cancer (pp. 51–87). Oxford: Oxford University Press.
48.
go back to reference Roscoe, J. A., Morrow, G. R., Hickok, J. T., Mustian, K. M., Griggs, J. J., Matteson, S. E., et al. (2005). Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Research and Treatment, 89(3), 243–249. CrossRefPubMed Roscoe, J. A., Morrow, G. R., Hickok, J. T., Mustian, K. M., Griggs, J. J., Matteson, S. E., et al. (2005). Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Research and Treatment, 89(3), 243–249. CrossRefPubMed
49.
go back to reference Morrow, G. R., Hickok, J. T., Roscoe, J. A., Raubertas, R. F., Andrews, P. L., Flynn, P. J., et al. (2003). Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. Journal of Clinical Oncology, 21(24), 4635–4641. CrossRefPubMed Morrow, G. R., Hickok, J. T., Roscoe, J. A., Raubertas, R. F., Andrews, P. L., Flynn, P. J., et al. (2003). Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. Journal of Clinical Oncology, 21(24), 4635–4641. CrossRefPubMed
50.
go back to reference Berger, A. M. (1998). Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncology Nursing Forum, 25(1), 51–62. PubMed Berger, A. M. (1998). Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncology Nursing Forum, 25(1), 51–62. PubMed
51.
go back to reference Mormont, M. C. (1997). Circadian-system alterations during cancer processes: A review. International Journal of Cancer, 70, 241–247. CrossRef Mormont, M. C. (1997). Circadian-system alterations during cancer processes: A review. International Journal of Cancer, 70, 241–247. CrossRef
52.
go back to reference Agteresch, H. J., Dagnelie, P. C., van der Gaast, A., Stijnen, T., & Wilson, J. H. (2000). Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer. Journal of the National Cancer Institute, 92(4), 321–328. CrossRefPubMed Agteresch, H. J., Dagnelie, P. C., van der Gaast, A., Stijnen, T., & Wilson, J. H. (2000). Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer. Journal of the National Cancer Institute, 92(4), 321–328. CrossRefPubMed
53.
go back to reference Segerstrom, S. C., & Miller, G. E. (2004). Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychological Bulletin, 130(4), 601–630. CrossRefPubMed Segerstrom, S. C., & Miller, G. E. (2004). Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychological Bulletin, 130(4), 601–630. CrossRefPubMed
54.
go back to reference Reyes-Gibby, C. C., Wu, X., Spitz, M., Kurzrock, R., Fisch, M., Bruera, E., et al. (2008). Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncology, 9(8), 777–785. CrossRefPubMed Reyes-Gibby, C. C., Wu, X., Spitz, M., Kurzrock, R., Fisch, M., Bruera, E., et al. (2008). Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncology, 9(8), 777–785. CrossRefPubMed
55.
go back to reference Reyes-Gibby, C. C., Spitz, M., Wu, X., Merriman, K., Etzel, C., Bruera, E., et al. (2007). Cytokine genes and pain severity in lung cancer: Exploring the influence of TNF-alpha-308 G/A IL6–174G/C and IL8–251T/A. Cancer Epidemiology, Biomarkers and Prevention, 16(12), 2745–2751. CrossRefPubMed Reyes-Gibby, C. C., Spitz, M., Wu, X., Merriman, K., Etzel, C., Bruera, E., et al. (2007). Cytokine genes and pain severity in lung cancer: Exploring the influence of TNF-alpha-308 G/A IL6–174G/C and IL8–251T/A. Cancer Epidemiology, Biomarkers and Prevention, 16(12), 2745–2751. CrossRefPubMed
56.
go back to reference Irwin, M. R., Miller, A. H., Irwin, M. R., & Miller, A. H. (2007). Depressive disorders and immunity: 20 years of progress and discovery. Brain, Behavior, and Immunity, 21(4), 374–383. CrossRefPubMed Irwin, M. R., Miller, A. H., Irwin, M. R., & Miller, A. H. (2007). Depressive disorders and immunity: 20 years of progress and discovery. Brain, Behavior, and Immunity, 21(4), 374–383. CrossRefPubMed
57.
go back to reference Collado-Hidalgo, A., Bower, J. E., Ganz, P. A., Irwin, M. R., & Cole, S. W. (2008). Cytokine gene polymorphisms and fatigue in breast cancer survivors: Early findings. Brain, Behavior, and Immunity, 22, 1197–1200. Collado-Hidalgo, A., Bower, J. E., Ganz, P. A., Irwin, M. R., & Cole, S. W. (2008). Cytokine gene polymorphisms and fatigue in breast cancer survivors: Early findings. Brain, Behavior, and Immunity, 22, 1197–1200.
58.
go back to reference Shafqat, A., Einhorn, L. H., Hanna, N., Sledge, G. W., Hanna, A., Juliar, B. E., et al. (2005). Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment. Annals of Oncology, 16(9), 1545–1550. CrossRefPubMed Shafqat, A., Einhorn, L. H., Hanna, N., Sledge, G. W., Hanna, A., Juliar, B. E., et al. (2005). Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment. Annals of Oncology, 16(9), 1545–1550. CrossRefPubMed
59.
go back to reference Whistler, T., Taylor, R., Craddock, R. C., Broderick, G., Klimas, N., Unger, E. R., et al. (2006). Gene expression correlates of unexplained fatigue. Pharmacogenomics, 7(3), 395–405. CrossRefPubMed Whistler, T., Taylor, R., Craddock, R. C., Broderick, G., Klimas, N., Unger, E. R., et al. (2006). Gene expression correlates of unexplained fatigue. Pharmacogenomics, 7(3), 395–405. CrossRefPubMed
60.
go back to reference Aspler, A. L., Bolshin, C., Vernon, S. D., Broderick, G., Aspler, A. L., Bolshin, C., et al. (2008). Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood. Behavioral and Brain Functions Electronic Resource: BBF, 4, 44. CrossRef Aspler, A. L., Bolshin, C., Vernon, S. D., Broderick, G., Aspler, A. L., Bolshin, C., et al. (2008). Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood. Behavioral and Brain Functions Electronic Resource: BBF, 4, 44. CrossRef
61.
go back to reference Kerr, J. R., Burke, B., Petty, R., Gough, J., Fear, D., Mattey, D. L., et al. (2008). Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: A detailed analysis of gene networks and clinical phenotypes. Journal of Clinical Pathology, 61(6), 730–739. CrossRefPubMed Kerr, J. R., Burke, B., Petty, R., Gough, J., Fear, D., Mattey, D. L., et al. (2008). Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: A detailed analysis of gene networks and clinical phenotypes. Journal of Clinical Pathology, 61(6), 730–739. CrossRefPubMed
62.
go back to reference Reyes, M., Nisenbaum, R., Hoaglin, D. C., Unger, E. R., Emmons, C., Randall, B., et al. (2003). Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Archives of Internal Medicine, 163(13), 1530–1536. CrossRefPubMed Reyes, M., Nisenbaum, R., Hoaglin, D. C., Unger, E. R., Emmons, C., Randall, B., et al. (2003). Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Archives of Internal Medicine, 163(13), 1530–1536. CrossRefPubMed
63.
go back to reference Plomin, R., DeFries, J. C., McClearn, G. E., & McGuffin, P. (2001). Behavioral Genetics. New York: Worth Publishers and W. H. Freeman and Co. Plomin, R., DeFries, J. C., McClearn, G. E., & McGuffin, P. (2001). Behavioral Genetics. New York: Worth Publishers and W. H. Freeman and Co.
64.
go back to reference Hartyl, D. L., & Jones, E. W. (Eds.). (2009). Genetics: Analysis of genes, genomes (7th ed.). Sudbury, Massachusetts: Jones and Bartlett. Hartyl, D. L., & Jones, E. W. (Eds.). (2009). Genetics: Analysis of genes, genomes (7th ed.). Sudbury, Massachusetts: Jones and Bartlett.
Metagegevens
Titel
I’m so tired: biological and genetic mechanisms of cancer-related fatigue
Auteurs
Andrea Barsevick
Marlene Frost
Aeilko Zwinderman
Per Hall
Michele Halyard
GENEQOL Consortium
Publicatiedatum
01-12-2010
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 10/2010
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9757-7